SERPINE1 and COVID-19: This process increases plasminogen activator inhibitor-1 (PAI-1) in ECs, which supports coagulation, endothelial activation, and inflammation.47 An increase in the levels of angiopoietin-248 and PAI-149 is observed in patients with COVID-19 and associates with thrombo-embolic events.